Taylor Ann Fera, | |
27 Boardman Rd, Charleston, SC 29407-3722 | |
(843) 200-9600 | |
Not Available |
Full Name | Taylor Ann Fera |
---|---|
Gender | Female |
Speciality | Specialist/technologist - Speech-language Assistant |
Location | 27 Boardman Rd, Charleston, South Carolina |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1134823776 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | 8296 (South Carolina) | Secondary |
2355S0801X | Specialist/technologist - Speech-language Assistant | 8296 (South Carolina) | Primary |
Mailing Address | Practice Location Address |
---|---|
Taylor Ann Fera, 27 Boardman Rd, Charleston, SC 29407-3722 Ph: (843) 200-9600 | Taylor Ann Fera, 27 Boardman Rd, Charleston, SC 29407-3722 Ph: (843) 200-9600 |
News Archive
According to the Internal Revenue Service, the federal government has delivered 330,000 premium subsidy calculations to people who have gotten far enough to find out whether they qualify for health insurance subsidies. Meanwhile, CNN looks deeper into some of the numbers currently being quoted.
Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.
Manhattan Cross Cultural Group is now offering a special introduction to the Quality Interactions® Patient Decision Support Tool for small healthcare organizations at http://www.qualityinteractions.org/index.new.html. This one-of-a-kind online resource allows healthcare organizations to access valuable information related to cross-cultural care to care for diverse patient populations at time of service.
St. Jude Medical, Inc., a global medical device company, today announced regulatory and reimbursement approval from the Australian Therapeutic Goods Administration of its Brio™ deep brain stimulation system for treating the symptoms of Parkinson's disease.
› Verified 6 days ago